Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47


Castleman Disease and Retinal Vascular Tortuosity.

Aung A, MacCumber MW.

JAMA Ophthalmol. 2017 Feb 9;135(2):e164660. doi: 10.1001/jamaophthalmol.2016.4660. Epub 2017 Feb 9. No abstract available.


Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599. Erratum in: JAMA Ophthalmol. 2016 Apr;134(4):469.


Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin.

McClintock M, MacCumber MW.

Clin Ophthalmol. 2015 Oct 23;9:1995-8. doi: 10.2147/OPTH.S85509. eCollection 2015.


Reply: To PMID 24457977.

Ferenchak K, MacCumber MW.

Retina. 2015 May;35(5):e29-30. doi: 10.1097/IAE.0000000000000601. No abstract available.


Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.

Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M; Diabetic Retinopathy Clinical Research Network Investigators.

JAMA Ophthalmol. 2015 May;133(5):589-97. doi: 10.1001/jamaophthalmol.2015.186.


The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.


Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.

Ferenchak K, Duval R, Cohen JA, MacCumber MW.

Retina. 2014 Jun;34(6):1177-81. doi: 10.1097/IAE.0000000000000058.


Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.

Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF; Macula Society CSC Collaborative Study Group, Research and Education Committee and Website Committee.

Ophthalmology. 2014 May;121(5):1073-8. doi: 10.1016/j.ophtha.2013.11.040. Epub 2014 Jan 16.


Author reply: To PMID 22944025.

Stone EM, Aldave AJ, Drack AV, MacCumber MW, Sheffield VC, Traboulsi E, Weleber RG.

Ophthalmology. 2013 Oct;120(10):e73. doi: 10.1016/j.ophtha.2013.07.008. No abstract available.


Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.

Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2013 Aug;131(8):1033-40. doi: 10.1001/jamaophthalmol.2013.4154.


Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.


Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.


Central serous chorioretinopathy associated with the use of spironolactone, aldosterone receptor antagonist.

Gabrielian A, MacCumber MW.

Retin Cases Brief Rep. 2012 Fall;6(4):393-5. doi: 10.1097/ICB.0b013e3182437db8.


Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing.

Stone EM, Aldave AJ, Drack AV, Maccumber MW, Sheffield VC, Traboulsi E, Weleber RG.

Ophthalmology. 2012 Nov;119(11):2408-10. doi: 10.1016/j.ophtha.2012.05.047. Epub 2012 Sep 1.


Subcutaneous diffuse large B-cell lymphoma with intraocular involvement.

Chi M, Bucher N, Gabrielian A, MacCumber MW, Zdunek T.

Future Oncol. 2012 Jun;8(6):757-60. doi: 10.2217/fon.12.40.


Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.


Diagnostic and therapeutic challenges.

Huang XY, Wang Y, Wang R, He GG, Gabrielian A, MacCumber MW.

Retina. 2012 Feb;32(2):399-402. doi: 10.1097/IAE.0b013e3182252aea. No abstract available.


Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.


Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus.

Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network.

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6168-73. doi: 10.1167/iovs.11-7321.


Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

Supplemental Content

Loading ...
Support Center